PLUR:NASDAQ
Pluri Inc
$1.08
0.00%
(0.00) 1D
$1.00
arrow_downward
-7.41% (-0.080)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
$1.08
High
$1.16
Low
$1.02
Mkt. cap
13.33M
Avg. vol.
23.95K
Volume
23.83K
52-wk high
$4.93
52-wk low
$1.02
EPS
-$2.44
Beta
0.68
Shares outstanding
12.34M
No. of employees
135
Open
$1.08
High
$1.16
Low
$1.02
Mkt. cap
13.33M
Avg. vol.
23.95K
Volume
23.83K
52-wk high
$4.93
52-wk low
$1.02
EPS
-$2.44
Beta
0.68
Shares outstanding
12.34M
No. of employees
135
News stories
From web sources and news partners
Benzinga
·
23 hours ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
CarePlus VietNam
·
1 month ago
PLUR Q2 2026 Earnings: Wider-Than-Expected Loss Highlights Clinical-Stage Investment - Strong Earnings Momentum
CarePlus VietNam
·
2 months ago
Pluri Inc. Q2 2026 Earnings: EPS Miss Reflects Ongoing R&D Investment - Annual Earnings Summary
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees135
FoundedMay 11, 2001
HeadquartersHaifa, Haifa District, Israel
SectorBiotechnology
Websitepluri-biotech.com